22EyesVision
Madrid-based ophthalmic medtech company, spun off from the Spanish National Research Council (CSIC) in 2015, that develops SimVis Gekko, a wearable binocular visual simulator letting patients preview presbyopia and cataract vision corrections (IOLs, trifocals, EDOF lenses, contact lenses) before surgery. Backed by Bullnet Capital, CDTI/INNVIERTE and Luminate, the company sells internationally across 18 countries and holds 8 patent families.
SectorsHealthtech & Bio, Medical Devices, Ophthalmology, Optics
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
C
Carlos Dorronsoro Díaz
CEO & Co-Founder
S
Susana Marcos
Co-Founder
Global models 5
R
RxSight
United States · www.rxsight.com ↗
VC-backed maker of light-adjustable intraocular lens technology that lets surgeons customize post-cataract-surgery vision correction, addressing the same presbyopia/cataract-correction workflow.
$194MComparable
AcuFocus
United States · acufocus.com ↗
VC-backed developer of small-aperture IOL and corneal inlay technology for presbyopia correction, targeting the same cataract/presbyopia surgical-outcome market.
~$200MComparable
L
LensGen
United States · lensgen.com ↗
VC-funded developer of accommodating (fluid-based) intraocular lenses restoring natural focus after cataract surgery, same presbyopia-correction IOL space.
~$90MComparable
PPresbia
United States/Netherlands · www.presbia.com ↗
VC-backed developer of a corneal microlens implant (Presbia Flexivue Microlens) to correct presbyopia, competing in the same surgical vision-correction niche.
~$150MComparable
V
Vivior AG
Switzerland · www.vivior.com ↗
VC-backed maker of a wearable lifestyle-monitoring device used to personalize IOL selection before cataract surgery — the closest business-model match as a pre-surgical decision-support device rather than the implant itself.
~$15MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 5
Open as list →
Funding rounds 4
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-04-30 | Series A (estimated) | €950K |
Lead not disclosed
+4 more
|
| 2023-12-13 | Series A (estimated) | €900K partial: only one investor's ticket was disclosed |
Lead not disclosed
+2 more
|
| 2020-11-24 | Series A (estimated) | €1.34M |
Bullnet Capital
+2 more
|
| 2017-12-12 | Series A | — | Bullnet Capital |
News 6
Open as list →| Published | Article |
|---|---|
| 2026-07-16 |
CDTI Innvierte destina en junio €96M a 7 nuevas coinversiones en capital riesgo y 1 vehículo de inversión ↗
Webcapitalriesgo
2026-07-16 |
| 2026-04-14 |
2EyesVision Launches SimVis Academy to Support Clinical Adoption of Preoperative Visual Simulation ↗
2EyesVision (press release)
2026-04-14 |
| 2026-02-11 |
Vision Simulators ↗
CRSToday
2026-02-11 |
| 2025-08-08 |
Carlos Dorronsoro, de 2EyesVision: "Nuestra propuesta no es solo innovadora, es clínicamente relevante" ↗
MuyPymes
2025-08-08 |
| 2025-06-30 |
2EyesVision launches SimVis Gekko2, the visual simulator ↗
2EyesVision (press release)
2025-06-30 |
| 2025-04-30 |
2EyesVision Boosts Global Expansion with €2 Million Capital Injection ↗
Empresa Exterior
2025-04-30 |